ArticleLearning health systems2026
Beyond Blind Trust in Hospital Data Warehouses: Evaluating Real-World Data Accountability.
Article in Learning health systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The reliability of real-world evidence (RWE) depends on data accuracy and secondary users' ability to evaluate how data are generated and transformed. Although recent frameworks emphasize provenance, transparency, and auditability, their practical assessment in routine hospital settings remains unclear. This study examines the practical evaluability of real-world data (RWD) and explores operational boundaries limiting data quality assessment within learning health systems. Methods: An empirical case study was conducted at a tertiary-care university hospital in Japan. Data extracted from electronic health records and a clinical data warehouse were compared using 15 quality indicators derived from the Results: Evaluability varied substantially across clinical domains. Diagnosis records were generally verifiable and explainable, whereas medication-related domains contained observations that could be verified but not fully explained by secondary users. Indicators including currentness and efficiency faced additional operational constraints, revealing boundaries between observable data characteristics and available explanatory information. Conclusions: Practical RWD use depends not only on observable data characteristics but also on the accessibility of information needed to interpret them. Evaluability boundaries reflect operational constraints rather than poor data quality. Rendering these boundaries visible may support more transparent and accountable RWD governance and inform future improvements through system design and data governance practices.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.